Stem the Tide of Predatory Stem Cell Clinics: State and FDA Coordination to Protect Patients
Journal of Science Policy & Governance · 2020
DOI: 10.38126/jspg170114 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Science Policy & Governance, 2020. Verfasst von Griffin McCutcheon und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Abstract (Originalsprache)
While stem cell therapies hold promise as regenerative treatments for combating a variety of conditions, the majority of these therapies remain in clinical trials without sufficient evidence for current clinical use. Predatory direct-to-consumer stem cell clinics (hereafter, DTC clinics), undeterred by a lack of clinical evidence, continue to offer unapproved stem cell injections to patients desperate to treat chronic conditions. These clinics can pose significant physical and financial harm to patients as their therapies are not without risks. Clinics rarely practice the requisite level of follow-up care required by clinical trials. To promote the safety and well-being of patients treated in stem cell clinics, we propose additional funding to support the Federal Food and Drug Administration (FDA) and state-level health departments’ oversight of DTC clinics. The FDA will likely experience a substantial financial burden from enforcing regulations, given that there are hundreds of DTC clinics in the U.S. This number is expected to continue rising, as evidenced by a 114% increase in DTC clinics between 2015 and 2017 (P. S. Knoepfler 2019). We propose that the FDA appropriate additional funding to support state level government enforcement and address this impending shortcoming. Additionally, we suggest state legislatures enact registry laws to prevent DTC clinics from avoiding federal regulations and enable local governments to address low-risk offenders as needed. These laws would enable states to take a more proactive role in patient protections, while also allowing the FDA to more effectively target its resources towards high-risk DTC business.
Zitieren
APA
McCutcheon, G., Malloy, J. F., Hall, C. A., & Barrett, C. (2020). Stem the Tide of Predatory Stem Cell Clinics: State and FDA Coordination to Protect Patients. Journal of Science Policy & Governance. https://doi.org/10.38126/jspg170114
Vancouver
McCutcheon G, Malloy JF, Hall CA, Barrett C. Stem the Tide of Predatory Stem Cell Clinics: State and FDA Coordination to Protect Patients. Journal of Science Policy & Governance. 2020. doi:10.38126/jspg170114
BibTeX
@article{McCutcheon2020,
author = {McCutcheon, Griffin and Malloy, John F. and Hall, Caitlyn A. and Barrett, Cassandra},
title = {Stem the Tide of Predatory Stem Cell Clinics: State and FDA Coordination to Protect Patients},
journal = {Journal of Science Policy & Governance},
year = {2020},
doi = {10.38126/jspg170114}
}
EUVIMED